- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1750-1172
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Genetic testing in diffuse parenchymal lung disease ; volume:7 ; number:1 ; day:17 ; month:10 ; year:2012 ; pages:1-8 ; date:12.2012
Orphanet journal of rare diseases ; 7, Heft 1 (17.10.2012), 1-8, 12.2012
- Urheber
-
Spagnolo, Paolo
- Beteiligte Personen und Organisationen
-
Luppi, Fabrizio
Cerri, Stefania
Richeldi, Luca
SpringerLink (Online service)
- DOI
-
10.1186/1750-1172-7-79
- URN
-
urn:nbn:de:1111-2016050121292
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 11:00 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Spagnolo, Paolo
- Luppi, Fabrizio
- Cerri, Stefania
- Richeldi, Luca
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diffuse parenchymal lung disease
Categorizing diffuse parenchymal lung disease in children
Transthoracic ultrasonographic features of diffuse parenchymal lung diseases
Classification and characterization of diffuse parenchymal lung diseases (DPLD) in childhood
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
Fayoum experience in the ultrasonographic evaluation of diffuse parenchymal lung disease
The role of medical thoracoscopic lung biopsy in diagnosis of diffuse parenchymal lung diseases
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities
Evaluation of large airway specimens obtained by transbronchial lung cryobiopsy in diffuse parenchymal lung diseases
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
Diffusion lung capacity for carbon monoxide correlates with HRCT findings in patients with diffuse parenchymal lung disease
Diffuse parenchymal lung disease
Categorizing diffuse parenchymal lung disease in children
Transthoracic ultrasonographic features of diffuse parenchymal lung diseases
Classification and characterization of diffuse parenchymal lung diseases (DPLD) in childhood
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
Fayoum experience in the ultrasonographic evaluation of diffuse parenchymal lung disease
The role of medical thoracoscopic lung biopsy in diagnosis of diffuse parenchymal lung diseases
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities
Evaluation of large airway specimens obtained by transbronchial lung cryobiopsy in diffuse parenchymal lung diseases
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
Diffusion lung capacity for carbon monoxide correlates with HRCT findings in patients with diffuse parenchymal lung disease
Diffuse parenchymal lung disease
Categorizing diffuse parenchymal lung disease in children
Transthoracic ultrasonographic features of diffuse parenchymal lung diseases
Classification and characterization of diffuse parenchymal lung diseases (DPLD) in childhood
Incidence and classification of pediatric diffuse parenchymal lung diseases in Germany
Fayoum experience in the ultrasonographic evaluation of diffuse parenchymal lung disease
The role of medical thoracoscopic lung biopsy in diagnosis of diffuse parenchymal lung diseases
Trans-bronchial forceps biopsy for COVID-19 related diffuse parenchymal lung abnormalities
Evaluation of large airway specimens obtained by transbronchial lung cryobiopsy in diffuse parenchymal lung diseases
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood
Diffuse parenchymal lung disease as first clinical manifestation of GATA-2 deficiency in childhood